2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: The Task Force for diabetes, pre-diabetes …

F Cosentino, PJ Grant, V Aboyans… - European heart …, 2020 - academic.oup.com
Health professionals are encouraged to take the Guidelines fully into account when
exercising their clinical judgment, as well as in the determination and the implementation of …

2018 ESC/EACTS Guidelines on myocardial revascularization

M Sousa-Uva, FJ Neumann, A Ahlsson… - European Journal of …, 2019 - academic.oup.com
These Guidelines represent the third time that the ESC and EACTS have brought together
cardiologists and cardiac surgeons in a joint Task Force to review the ever-increasing body …

2023 AHA/ACC/ACCP/ASPC/NLA/PCNA guideline for the management of patients with chronic coronary disease: a report of the American Heart Association …

Writing Committee Members, SS Virani… - Journal of the American …, 2023 - jacc.org
Abstract Aim The “2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management
of Patients With Chronic Coronary Disease” provides an update to and consolidates new …

2021 ACC/AHA/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology/American Heart Association Joint Committee on …

Writing Committee Members, JS Lawton… - Journal of the American …, 2022 - jacc.org
Aim The guideline for coronary artery revascularization replaces the 2011 coronary artery
bypass graft surgery and the 2011 and 2015 percutaneous coronary intervention guidelines …

2018 ESC/EACTS Guidelines on myocardial revascularization

FJ Neumann, M Sousa-Uva, A Ahlsson… - European heart …, 2019 - academic.oup.com
always refer to the full text version, which is freely available on the ESC and EACTS
websites. The National Societies of the ESC are encouraged to endorse, translate, and …

Everolimus-eluting stents or bypass surgery for left main coronary artery disease

GW Stone, JF Sabik, PW Serruys… - … England Journal of …, 2016 - Mass Medical Soc
Background Patients with obstructive left main coronary artery disease are usually treated
with coronary-artery bypass grafting (CABG). Randomized trials have suggested that drug …

Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open …

T Mäkikallio, NR Holm, M Lindsay, MS Spence, A Erglis… - The Lancet, 2016 - thelancet.com
Background Coronary artery bypass grafting (CABG) is the standard treatment for
revascularisation in patients with left main coronary artery disease, but use of percutaneous …

Coronary computed tomography angiography for heart team decision-making in multivessel coronary artery disease

C Collet, Y Onuma, D Andreini, J Sonck… - European Heart …, 2018 - academic.oup.com
Aims Coronary computed tomography angiography (CTA) has emerged as a non-invasive
diagnostic method for patients with suspected coronary artery disease, but its usefulness in …

Quality-of-life after everolimus-eluting stents or bypass surgery for left-main disease: results from the EXCEL trial

SJ Baron, K Chinnakondepalli, EA Magnuson… - Journal of the American …, 2017 - jacc.org
Abstract Background: The EXCEL (Evaluation of Xience Versus Coronary Artery Bypass
Surgery for Effectiveness of Left Main Revascularization) trial compared outcomes in …

Left main coronary artery disease: pathophysiology, diagnosis, and treatment

C Collet, D Capodanno, Y Onuma, A Banning… - Nature Reviews …, 2018 - nature.com
The advent of coronary angiography in the 1960s allowed for the risk stratification of patients
with stable angina. Patients with unprotected left main coronary artery disease have an …